期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

国产雷帕霉素洗脱支架和进口紫杉醇洗脱支架对照研究 被引量：1

下载PDF
导出
摘要 目的比较国产雷帕霉素洗脱支架(EXCEL)和进口新型紫杉醇洗脱支架(TAXUS)的长期有效性和安全性。方法选择符合冠心病介入治疗标准的患者106例,随机选择EXCEL和TAXUS支架治疗,其中EXCEL组55例,TAXUS组51例。比较两组冠状动脉造影参数及术后3 a随访死亡、心肌梗死、支架内血栓和靶血管血运重建等不良事件发生率。结果 3 a随访,死亡、心肌梗死、支架内血栓和靶血管血运重建单个不良事件差异无统计学意义(P>0.05)。EXCEL组、TAXUS组总不良事件发生率分别为12.7%、17.6%,两组比较差异无统计学意义(P>0.05)。结论两种支架在临床长期随访均显示了较高的安全性和较好的有效性,均可以作为介入治疗的一线选择,值得推广。
作者 陈少伯 岳继华 梁国庆 赵季红 姜铁民 李玉明
机构地区 天津医科大学 武警医学院附属医院
出处 《山东医药》 CAS 北大核心 2010年第52期85-86,共2页 Shandong Medical Journal
关键词 冠状动脉疾病 血管成形术 经腔 经皮冠状动脉 支架 雷帕霉素 紫杉醇
分类号 R541.4 [医药卫生—心血管疾病]
  • 相关文献

参考文献6

  • 1张玉霄,卢才义,薛桥,刘鹏,颜伟,吴兴利,陈瑞.载雷帕霉素可降解聚合物涂层支架治疗冠心病的临床观察[J].中华心血管病杂志,2006,34(11):971-974. 被引量：19
  • 2Turco MA,Ormiston JA,Popma JJ,et al.Polymer-based,paclitaxel-eluting TAXUS Liberté stent in de novo lesions:the pivotal TAXUS ATLAS trial[J].J Am Coll Cardiol,2007,49(16):1676-1683.
  • 3岳继华,陈少伯,柴晓红,赵季红,姜铁民.国产西莫罗司洗脱支架和新型紫杉醇洗脱支架在冠状动脉病变治疗中的对比研究和1年随访[J].临床荟萃,2008,23(17):1219-1222. 被引量：4
  • 4Escolar E,Mintz GS,Popma J,et al.Meta-analysis of angiographic versus intravascular ultrasound parameters of drug-eluting stent efficacy(from TAXUS Ⅳ,Ⅴ,and Ⅵ)[J].Am J Cardiol,2007,100(4):621-626.
  • 5Chacko R,Mulhearn M,Novack V,et al.Impact of target lesion and nontarget lesion cardiac events on 5-year clinical outcomes after sirolimus-eluting or bare-metal stenting[J].JACC Cardiovasc Interv,2009,2(6):498-503.
  • 6Di Lorenzo E,De Luca G,Ssuro R,et al.The PASEO(PaclitAxel or Sirolimus-Eluting Stent Versus Bare Metal Stent in Primary Angioplasty)Randomized Trial[J].JACC Cardiovasc Interv,2009,2(6):515-523.

二级参考文献23

  • 1张玉霄,卢才义,薛桥,刘鹏,颜伟,吴兴利,陈瑞.载雷帕霉素可降解聚合物涂层支架治疗冠心病的临床观察[J].中华心血管病杂志,2006,34(11):971-974. 被引量：19
  • 2Dussaillant GR, Mintz GS, Pichard AD, et al. Small stent size and intimal hyperplasia contribute to restenosis : a volumetric intravascular ultrasound analysis. J Am Coll Cardiol, 1995, 26:720-724.
  • 3Hoffmann R, Mintz GS, Dussaillant GR, et al. Patterns and mechanisms of in-slenl reslenosis. A serial intravascular ultrasound study. Circulation, 1996, 94: 1247-1254.
  • 4Schofer J, Schluter M, Gershlick AH, et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (ESIRIUS). Lancet, 2003, 362: 1093-1099.
  • 5Schampaert E, Cohen EA, Schluter M, et at. The Canadian study of the sirolimus-eluling stent in the treatment of patients with long denovo lesions in small native coronary arteries ( C-SIRIUS ). J Am Coll Cardiol, 2004, 43: 1110-1115.
  • 6Lemos PA, Serruys PW, van Domburg RT, et al. Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world" : the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry.Circulation, 2004, 109: 190-195.
  • 7Sousa JE, Costa MA, Abizaid A, et al. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and threedimensional intravascular ultrasound study. Circulation, 2001, 103 :192-195.
  • 8Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluling stent with a standard stent for coronary revascularization. N Engl J Med, 2002, 346: 1773-1780.
  • 9Serruys PW, Degertekin M, Tanabe K, et al . Intravascular ultrasound findings in the multicenter, randomized , double-blind RAVEL (RAndomized study with the sirolimus-eluting Velocity balloon-expandable slenl in the treatment of patients with de novo native coronary, artery Lesions) trial. Circulation, 2002, 106: 798-803.
  • 10Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med, 2003, 349: 1315-1323.

共引文献20

同被引文献27

  • 1王哲颖,刘同库.雷帕霉素洗脱支架治疗无保护冠状动脉左主干严重狭窄性病变的安全性和远期效果研究[J].中国全科医学,2013,16(27):3192-3195. 被引量：10
  • 2Kereiakes D J, Cannon LA, Feldman RL, et aI.Clinical and angiographic outcomes after treatment of de novo coronary stenoses with a novel platinum chromium thin-strut stent: primary results of the PERSEUS (Prospective Evaluation in a Randomized Trial of the Safety and Efficacy of the Use of the TAXUS Element PaclitaxeI-Eluting Coronary Stent System) trial.J Am Coil Cardiol. 2010;56(4):264-271.
  • 3Kimura T, Morimoto T, Nakagawa Y, et aI.Very late stent thrombosis and late target lesion revascularization after sirolimus-eluting stent implantation: five-year outcome of the j-Cypher Registry.Circulation. 2012; 125(4):584-591.
  • 4Spaulding C, Teiger E, Commeau P, et aLFour-year follow-up of TYPHOON (trial to assess the use of the CYPHer sirolimus-eluting coronary stent in acute myocardial infarction treated with BallOON angioplasty). JACC Cardiovasc I nterv. 2011 ;4(1 ):14-23.
  • 5Ma Q, Zhou Y, Nie X, et aI.Rapamycin affects tissue plasminogen activator and plasminogen activator inhibitor I expression: a potential prothrombotic mechanism of drug-eluting stents.Angiology. 2012; 63(5) 330-335.
  • 6Nakazawa G, Finn AV, Vorpahl M, et al.Coronary responses and differential mechanisms of late stent thrombosis attributed to first-generation sirolimus- and paclitaxel-eluting stents.J Am Coil Cardiol. 2011;57(4): 390-398.
  • 7Rber L, Magrc M, Stefanini GG, et aI.Very late coronary stent thrombosis of a newer-generation everolimuseluting stent compared with early-generation drug-eluting stents: a prospective cohort study.Circulation. 2012;125(9):1110-1121.
  • 8庞明杰,张宏,赵燕,等.依维莫司洗脱支架在急性冠脉综合征中应用的效果分析[J].医药前沿,2013,(10):60-61.
  • 9Townsend JC, Rideout P, Steinberg DH. Everolimus-eluting stents in interventional cardiology. Vasc Health Risk Manag. 2012;8:393-404.
  • 10Leon MB, Mauri L, Popma J J, et aI.A randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paditaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV triaI,J Am Coil Cardiol. 2010;55(6):543-554.

引证文献1

二级引证文献5

山东医药
2010年 第52期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部